The top 100 venture investors in biotech 2020
The top 100 venture investors in biotech 2020 by Endpoints News: 4 venture firms ranked. The entries on record, movement since the last edition, and method notes.
- Publisher
- Endpoints News
- Published
- February 18, 2020
- On this page
- 4 of 100 ranked
- Method
- Data
- Reliability
- Grade A
Covers 2019, when tracked biotech venture investing fell to $14.06 billion from $16.02 billion. By deal count OrbiMed led the top 100 with 20 deals.
The list on record
This page shows the 4 entries on record of 100 published. Only deal counts for four firms are quoted in the free text (reproduced by J Rich Capital). These are a deal-count sort within the top 100, not necessarily the list's rank order, so rank is left null. See the original list.
| Rank | Name |
|---|---|
| OrbiMedDeals: 20 | |
| AlexandriaDeals: 18 | |
| PerceptiveDeals: 16 | |
| RA CapitalDeals: 16 |
This list is reproduced as Endpoints News published it. Names are shown as printed. The ranking belongs to its publisher.
Sources and known limits
A reviewed date is not available for this page.